MA44558B1 - Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof - Google Patents

Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof

Info

Publication number
MA44558B1
MA44558B1 MA44558A MA44558A MA44558B1 MA 44558 B1 MA44558 B1 MA 44558B1 MA 44558 A MA44558 A MA 44558A MA 44558 A MA44558 A MA 44558A MA 44558 B1 MA44558 B1 MA 44558B1
Authority
MA
Morocco
Prior art keywords
conjugate
composition
therapeutic use
glucagon derivative
glucagon
Prior art date
Application number
MA44558A
Other languages
French (fr)
Other versions
MA44558A1 (en
Inventor
Sung Youb Jung
In Young Choi
Jung Kuk Kim
Young Jin Park
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Priority claimed from PCT/KR2017/006922 external-priority patent/WO2018004283A2/en
Publication of MA44558A1 publication Critical patent/MA44558A1/en
Publication of MA44558B1 publication Critical patent/MA44558B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un dérivé du glucagon, un conjugué de celui-ci, une composition le comprenant et une utilisation de celui-ci. L'invention concerne plus particulièrement une utilisation thérapeutique pour le syndrome métabolique, l'hypoglycémie et l'hyperinsulinémie concomitante.The present invention relates to a derivative of glucagon, a conjugate thereof, a composition comprising it and a use thereof. The invention relates more particularly to a therapeutic use for metabolic syndrome, concomitant hypoglycemia and hyperinsulinemia.

MA44558A 2016-06-29 2017-06-29 Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof MA44558B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160081995 2016-06-29
PCT/KR2017/006922 WO2018004283A2 (en) 2016-06-29 2017-06-29 Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof

Publications (2)

Publication Number Publication Date
MA44558A1 MA44558A1 (en) 2020-02-28
MA44558B1 true MA44558B1 (en) 2022-04-29

Family

ID=63963830

Family Applications (1)

Application Number Title Priority Date Filing Date
MA44558A MA44558B1 (en) 2016-06-29 2017-06-29 Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof

Country Status (2)

Country Link
AR (1) AR108969A1 (en)
MA (1) MA44558B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115634285A (en) * 2021-07-20 2023-01-24 派格生物医药(苏州)股份有限公司 Application of polypeptide conjugate in preparation of medicines for treating diseases related to glycometabolism

Also Published As

Publication number Publication date
AR108969A1 (en) 2018-10-17
MA44558A1 (en) 2020-02-28

Similar Documents

Publication Publication Date Title
PH12018502742A1 (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
MA49545B1 (en) Glucagon derivative and composition comprising a long-acting conjugate thereof
CL2022000448A1 (en) Autoinjector (divisional application no. 201903061)
CL2022000027A1 (en) PCSK9 antagonist compounds. (Application divisional 202003257).
UY37278A (en) ANTI-B7-H3 ANTIBODIES AND DRUG AND ANTIBODY CONJUGATES
MA43518A (en) 3-AZABICYCLO [3.1.0] SUBSTITUTED HEXANES SERVING AS KETOHEXOKINASE INHIBITORS
MA39362A1 (en) Stable compositions of uncomplexed iodine and methods of use
BR112017008666A2 (en) anti-fgfr2 / 3 antibodies and methods of use
EA201690613A1 (en) IMPROVED COMPOSITIONS BASED ON ADENOVIRUSES
EA201900562A1 (en) BIS-OCTAGHYDROPHENANTHRENE CARBOXAMIDES AND THEIR PROTEIN CONJUGATES
EA201591805A1 (en) OXABICICLO [2.2.2] ACIDS - MODULATORS GPR120
EA202190708A1 (en) EXPRESSION MODULATORS PNPLA3
EA201692204A1 (en) COMPOSITIONS AND METHODS OF MODULATING THE EXPRESSION OF COMPLEX B FACTOR
PH12019501018A1 (en) Pharmaceutical composition, methods for treating and uses thereof
EA201892119A1 (en) DRUGS, OBTAINED BY COMBINING AGONIST FXR AND ARB
BR112015019587A2 (en) combinations comprising maba compounds and corticosteroids
CL2016003023A1 (en) "Compounds derived from (benzyl-piperazin-1-yl) (tetrahydrofuran-carbonyl or tetrahydropyran-carbonyl) substituted, rorg modulators; pharmaceutical composition comprising them; and its use in the treatment of multiple sclerosis and ankylosing spondylitis. ” pct
EP4293116A3 (en) Stable liquid fibrinogen
EA201792262A1 (en) PIROGLUTAMAT VORTIOKSETINA
EA201791716A1 (en) PHARMACEUTICAL COMPOSITION
EA202191471A1 (en) ANTI-INFLAMMATORY POLYPEPTIDES
SV2018005701A (en) 1,3,4-TIADIAZOL COMPOUNDS AND THEIR USE IN CANCER TREATMENT
MA44558A1 (en) Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof
CL2019003249A1 (en) Improved protocol for the treatment of lupus nephritis.
MX2020003554A (en) MODULATORS OF ENaC EXPRESSION.